PULSARCI100 and SONATATI100
Cochlear Implants
The PULSARCI100 and SONATATI100 cochlear implants represent a culmination of decades of research and development. Introducing the new I100 electronics platform, PULSARCI100 and SONATATI100 provide cochlear implant recipients the opportunity to benefit from the absolute latest advances in technology – today and tomorrow.
 |
|
MED-EL’s highly advanced I100 electronics platform provides implant users access to the most sophisticated sound coding strategies available more...
|
|
 |
|
For decades, the greatest challenges in cochlear implant performance have included music enjoyment and speech understanding in noise more...
|
|
 |
|
The PULSARCI100 and SONATATI100 are designed to support a wide range of telemetry and assessment functions, enabling CI professionals to test implant function precisely and to monitor the interaction between the implant and the auditory nerve more...
|
|
 |
|
The PULSARCI100 and SONATATI100 are safe for Magnetic Resonance Imaging (MRI) at 0.2, 1.0 and 1.5 Tesla more...
|
|
 |
|
MED-EL leads the cochlear implant industry in providing especially soft and flexible electrode arrays that stimulate a maximum number of nerve fibres for a hearing experience coversing the broadest frequency range more...
|
|
Product specific information:
|
|
|
|
|
|
|
